Novel PDE4B inhibitor offers breakthrough for IPF
Findings from a phase 2, randomized, placebo-controlled trial in patients with idiopathic...
Read MoreMay 18, 2022
Findings from a phase 2, randomized, placebo-controlled trial in patients with idiopathic...
Read MoreMay 2, 2022
Certain blood biochemical markers may have an important role in the pathogenesis of schizophrenia...
Read MoreApr 28, 2022
Molecular classification served as a significant marker of survival following endometrial cancer...
Read MoreApr 27, 2022
Black women experience higher mortality from endometrial cancer (EC) than White women, according...
Read MoreApr 27, 2022
Recent findings support the notion of metastasectomy being linked with an overall survival (OS)...
Read MoreApr 26, 2022
Preoperative PET scanning among patients with high-risk, clinical stage 1 endometrial cancer (EC)...
Read MoreApr 26, 2022
Only one-third of patients with asthma treated with inhaled corticosteroids (ICS) had a regular or...
Read MoreApr 26, 2022
Inebilizumab, an anti-CD19, B-cell depleting monoclonal antibody for adults with aquaporin-4...
Read MoreApr 26, 2022
A nomogram statistical model may play a major role in predicting the early death of patients with...
Read MoreApr 25, 2022
Immunotherapy is underutilized in patients with advanced endometrial cancer (EC), even though...
Read MoreApr 25, 2022
The COVID-19 pandemic had a major effect on access to gynecologic care for women of all races and...
Read MoreApr 25, 2022
Prior research has examined sentinel lymph node (SLN) mapping among patients with a range of BMI...
Read More